11 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
17267215	27	Oxazolidinones as novel human CCR8 antagonists.	Glaxosmithkline
19954248	85	Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites.	Astrazeneca
18257512	33	Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships.	Astrazeneca
22957890	174	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.	University of Copenhagen
17266208	104	Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8.	Millennium Pharmaceuticals
16698264	37	Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.	Merck Research Laboratories
16640325	41	Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).	Millennium Pharmaceuticals
31913038	13	Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.	University of Florida
23409871	48	Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.	Glaxosmithkline
29406702	128	Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists.	Gsk Pharmaceuticals R & D